Updated Data on Gilteritinib in AML

Updated Data on Gilteritinib in AML
Don Photo

Don
3 साल 48 चेतावनी
वर्ग:
विवरण:
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on the importance of the updated data on gilteritinib in acute myeloid leukemia (AML).